Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
07:05pm, Monday, 16'th Sep 2024
Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day.
Investors Are Underestimating The Potential Of Vertex's Non-Addictive Pain Drug
01:59pm, Sunday, 15'th Sep 2024
Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than placebos
3 Stocks to Buy and Hold Forever
07:30am, Saturday, 14'th Sep 2024
AbbVie has proved it can adapt to a fast-changing environment. Eli Lilly has a sustainable culture of growth.
Prediction: These 3 Phenomenal Stocks Are Set to Soar
05:42am, Saturday, 14'th Sep 2024
One of these stocks stands to benefit from interest rate cuts that could be on the way. Another will soon launch a new product that could become its most successful ever.
Is Most-Watched Stock Vertex Pharmaceuticals Incorporated (VRTX) Worth Betting on Now?
10:02am, Friday, 13'th Sep 2024
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vertex Stock Loses Around $3B in 3 Months: Buy the Dip or Steer Clear?
12:45pm, Wednesday, 11'th Sep 2024
VRTX is a good stock to have in one's portfolio based on its strong overall financial performance and robust pipeline progress.
Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
04:25pm, Thursday, 05'th Sep 2024
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX ) Morgan Stanley Conference Call September 5, 2024 11:30 AM ET Company Participants Reshma Kewalramani - President and CEO Charlie Wagner - CFO Conference Cal
Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced
01:00am, Thursday, 05'th Sep 2024
Vertex Pharmaceuticals, a leader in Cystic Fibrosis treatment, reported strong financials in Q2 but faces limited growth in CF due to high market penetration. Despite a GAAP net loss in Q2, Vertex rem
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 02'nd Sep 2024
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
3 No-Brainer Stocks to Buy in September
07:30am, Saturday, 31'st Aug 2024
Eli Lilly is a growth machine that never runs out of opportunities. Novo Nordisk is still gaining momentum.
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
06:45am, Friday, 30'th Aug 2024
Abbott Labs produces medications as just one of its revenue sources. AbbVie has shown a knack for expanding the markets of its drugs.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
05:50am, Friday, 30'th Aug 2024
Vertex enjoys a monopoly that could soon grow stronger. The company could have multiple potential blockbuster drugs on the way.
Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control
08:00am, Thursday, 29'th Aug 2024
MENLO PARK, Calif.--(BUSINESS WIRE)-- #FDA--FDA approves U.S. pivotal trial of Jupiter Endovascular pulmonary embolism system with Endoportal Control technology.
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday
07:01pm, Wednesday, 28'th Aug 2024
Shares of several drugmakers and biotechnology firms moved higher on Wednesday, notching some of the day's top performances in the S&P 500.
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
05:45am, Friday, 23'rd Aug 2024
Vertex Pharmaceuticals is different from Novo Nordisk in several ways. The two companies could compete against each other in the future.
